Nexalin Technology, Inc. (NXL) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nexalin Technology, Inc., a Delaware corporation headquartered in Houston, Texas, on October 15, 2025. The report discloses the entry into a material definitive agreement regarding the company's capital raising activities.
Key Financial Metrics and Capital Structure
The filing does not provide specific revenue, profit, cash flow, or margin data. The primary financial disclosure relates to the company's "at-the-market" (ATM) equity distribution program:
- Program Cap Increase: The maximum aggregate offering price for shares sold under the ATM Program was increased from $3,100,000 to $10,000,000.
- Available Capacity: As of October 15, 2025, approximately $4,273,859 in shares remain available for sale under the amended program.
- Agent: Maxim Group LLC serves as the exclusive sales agent.
Material Changes
The material change reported is the execution of Amendment No. 2 to the Equity Distribution Agreement dated April 29, 2025. This amendment significantly expanded the company's ability to raise capital through the ATM Program by more than tripling the total offering limit.
Outlook, Risks, and Management Commentary
Management has authorized the expansion of the ATM Program to facilitate the sale of common stock from time to time. The filing notes that the shares will be issued pursuant to an effective shelf registration statement on Form S-3. No specific forward-looking guidance on revenue or earnings is provided in this document. The filing includes standard legal disclaimers stating that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Key Facts for Investor Verification
- Verify the current market price of NXL common stock to assess potential dilution from future ATM sales.
- Review the full text of Amendment No. 2 (Exhibit 10.1) for specific terms, commissions, and termination rights.
- Monitor subsequent filings to track the actual volume of shares sold and proceeds raised under the expanded $10,000,000 limit.
- Confirm the company's current cash position and liquidity needs to understand the urgency of utilizing the ATM Program.